A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.
From 2019 to 2024, there was an increase in early lung cancer detection and decrease in local/advanced diagnosis.
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
Morning Overview on MSN
New ORACLE gene test flags lung cancer spread risk before surgery
A patient walks into a thoracic surgery consultation with a small lung tumor, stage I on every scan, and every conventional ...
Lung cancer is the deadliest cancer—but early screening can save lives. A survivor’s story and expert insight show why ...
A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in ...
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results